Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Report

Global and Region Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：220
  • REPORT CODE：GMM968121
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeuticsmarket, defines the market attractiveness level of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics industry, describes the types of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market and the development prospects and opportunities of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics market in Chapter 13.

    By Player:

    • Janssen Pharmaceuticals, Inc

    • Amedra Pharmaceuticals LLC

    • Noven Pharmaceuticals, Inc

    • Celltech Group Ltd

    • Shire

    • Novartis Pharmaceuticals Corporation

    • Eli Lilly and Company

    • Purdue Pharma LP

    • GlaxoSmithKline

    By Type:

    • Stimulants

    • Non-stimulants

    By End-User:

    • Specialty Clinics

    • Hospital Pharmacies

    • Retail Pharmacies

    • E-Commerce

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption (2017-2022)

    • 7.2 United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption (2017-2022)

    • 7.4 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption (2017-2022)

    • 7.6 India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast (2022-2028)

    9 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Stimulants Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Non-stimulants Consumption and Growth Rate (2017-2022)

    • 9.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Specialty Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global E-Commerce Consumption and Growth Rate (2017-2022)

    10 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Non-stimulants Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)

    11 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Competitive Analysis

    • 14.1 Janssen Pharmaceuticals, Inc

      • 14.1.1 Janssen Pharmaceuticals, Inc Company Details

      • 14.1.2 Janssen Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Janssen Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.2 Amedra Pharmaceuticals LLC

      • 14.2.1 Amedra Pharmaceuticals LLC Company Details

      • 14.2.2 Amedra Pharmaceuticals LLC Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Amedra Pharmaceuticals LLC Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.3 Noven Pharmaceuticals, Inc

      • 14.3.1 Noven Pharmaceuticals, Inc Company Details

      • 14.3.2 Noven Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Noven Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.4 Celltech Group Ltd

      • 14.4.1 Celltech Group Ltd Company Details

      • 14.4.2 Celltech Group Ltd Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Celltech Group Ltd Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.5 Shire

      • 14.5.1 Shire Company Details

      • 14.5.2 Shire Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Shire Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.6 Novartis Pharmaceuticals Corporation

      • 14.6.1 Novartis Pharmaceuticals Corporation Company Details

      • 14.6.2 Novartis Pharmaceuticals Corporation Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Novartis Pharmaceuticals Corporation Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.7 Eli Lilly and Company

      • 14.7.1 Eli Lilly and Company Company Details

      • 14.7.2 Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.8 Purdue Pharma LP

      • 14.8.1 Purdue Pharma LP Company Details

      • 14.8.2 Purdue Pharma LP Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Purdue Pharma LP Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • 14.9 GlaxoSmithKline

      • 14.9.1 GlaxoSmithKline Company Details

      • 14.9.2 GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics

    • Figure Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Picture

    • Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stimulants Consumption and Growth Rate (2017-2022)

    • Figure Global Non-stimulants Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global E-Commerce Consumption and Growth Rate (2017-2022)

    • Figure Global Stimulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-stimulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global E-Commerce Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Janssen Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table Amedra Pharmaceuticals LLC (Foundation Year, Company Profile and etc.)

    • Table Amedra Pharmaceuticals LLC Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amedra Pharmaceuticals LLC Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table Noven Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Noven Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Noven Pharmaceuticals, Inc Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table Celltech Group Ltd (Foundation Year, Company Profile and etc.)

    • Table Celltech Group Ltd Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celltech Group Ltd Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table Shire (Foundation Year, Company Profile and etc.)

    • Table Shire Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Shire Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table Novartis Pharmaceuticals Corporation (Foundation Year, Company Profile and etc.)

    • Table Novartis Pharmaceuticals Corporation Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Pharmaceuticals Corporation Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table Purdue Pharma LP (Foundation Year, Company Profile and etc.)

    • Table Purdue Pharma LP Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Purdue Pharma LP Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Attention-Deficit Hyperactivity Disorder (ADHD) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US